Becker's Healthcare November 26, 2024
Paige Twenter

GLP-1 medications like Mounjaro and Saxenda might benefit stroke survivors and reduce some patients’ healthcare costs, according to researchers.

Here are six recent GLP-1 studies:

1. The use of Ozempic and Wegovy reduced healthcare costs for overweight or obese patients with heart failure or atherosclerotic cardiovascular disease, according to studies presented Nov. 3-6 at the Obesity Society’s annual Obesity Week conference.

Among 806 patients with heart failure, average annual medical costs declined $7,502, from $29,654 before treatment to $22,152 after treatment. Among 1,282 patients with atherosclerotic cardiovascular disease, the average total medical cost fell by $9,276, or from $25,233 to $15,957.

2. Stroke survivors who took GLP-1 or sodium-glucose cotransporter-2 inhibitor medications had a 74% lower...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Pharma / Biotech, Survey / Study, Trends
Related Articles:
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
A Biologist Explains The ‘Weird’ Habits Of People Who Live To 100+ Years Old
U.S. Health Care Spending Reaches $4.9 Trillion
Medicaid spending on weight loss, diabetes drugs up 500% since 2019: 5 numbers to know
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Share This Article